RBC Capital Upgrades Celgene (CELG) to Outperform
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Rating Summary:
7 Buy, 27 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
7 Buy, 27 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
RBC Capital upgraded Celgene (NASDAQ: CELG) from Sector Perform to Outperform, price target raised from $65 to $75.
For more ratings news on Celgene click here and for the rating history of Celgene click here.
Shares of Celgene closed at $62.95 yesterday.
For more ratings news on Celgene click here and for the rating history of Celgene click here.
Shares of Celgene closed at $62.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- Fox Advisors Upgrades Fabrinet (FN) to Overweight 'after its healthy FQ4 (Jun) “beat and raise” that was quickly dismissed by investors'
- Citi Upgrades JSL SA (JSLG3:BZ) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
